Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL351P is a processed pseudogene derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) complex[1]. While the canonical 7SL RNA is essential for SRP-mediated protein translocation to membranes, RN7SL351P itself does not encode a functional RNA or protein and is believed to lack biological activity in humans[1][2]. Unlike functional 7SL RNA (which is ~300 nucleotides and part of the SRP ribonucleoprotein complex), RN7SL351P carries mutations or deletions typical of pseudogenes and is regarded as a noncoding genomic element. No literature indicates direct clinical, drug, or biomarker relevance of RN7SL351P, and its presence in genome annotation primarily reflects evolutionary duplication and inactivation[1][2].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 351, pseudogene (RN7SL351P).